Science Explorer Interactive view Map
Nonprofit · London · United Kingdom

Breast Cancer Now

In research, Breast Cancer Now stands highest in Life Sciences (#3,440 of 14,347 worldwide), Medicine (#5,432 of 17,978 worldwide) and Health Sciences (#7,251 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Biochemistry, Genetics and Molecular Biology — Biochemistry, Genetics and Molecular Biology is 6.8× its share of world research.

breastcancernow.orgROR OpenAlex
World rank, 2022–2025
#8,344
of 28,054 · #7,711 all time
Rank in United Kingdom
#313
of 1,094
Research works
488
▲ 4% vs 2013–17
Citations
40k
81.0 per fractional work
Top-10% rate
38.2%
record average 16.5%
Open access
58%
world 28%

What is Breast Cancer Now known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #3,440 of 14,347 40.9%266
MedicineField #5,432 of 17,978 36.8%204
Health SciencesDomain #7,251 of 20,462 36.6%206
Biochemistry, Genetics and Molecular BiologyField #2,809 of 7,814 40.8%235

Each strip is that field’s whole ranked pool, with the notch where Breast Cancer Now sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Breast Cancer Now specialise in?

Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 6.8× the share of its output that it takes of world research.

  1. Biochemistry, Genetics and Molecular BiologyField · 23.5 works6.8×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.04× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.84× its world share, 24 worksBiochemistry, Geneti…Immunology and Microbiology: 7.43× its world share, 5 worksImmunology and Micro…Neuroscience: 1.13× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.24× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.37× its world share, 0 worksChemistryComputer Science: 0.25× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.11× its world share, 0 worksEarth and Planetary …Engineering: 0.08× its world share, 1 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.04× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.02× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.63× its world share, 1 worksHealth ProfessionsMedicine: 2.34× its world share, 29 worksMedicineNursing: 0.45× its world share, 0 worksNursingBusiness, Management and Accounting: 0.03× its world share, 0 worksBusiness, Management…Decision Sciences: 0.94× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.56× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.03× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.4×. Every wedge is a field page.

Who are the top researchers at Breast Cancer Now?

Ranked on the composite score, Richard Buus lead among researchers whose main affiliation is Breast Cancer Now.

  1. 1 Richard Buus United Kingdom · #1,463,667 worldwide 26 citations · 23 works
All ranked researchers at Breast Cancer Now

Which keywords describe research at Breast Cancer Now?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Breast Cancer, Cancer Therapy, Gene Expression, Cancer, Cell Death, Homologous Recombination, Radiotherapy and Genomic Instability.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Breast Cancer7▲ 48×11 topics
  2. Cancer Therapy6▲ 17×8 topics
  3. Cancer6▲ 6.6×29 topics
  4. Gene Expression5▲ 14×9 topics
  5. Cell Death5▲ 30×6 topics
  6. Homologous Recombination4▲ 155×2 topics
  7. Radiotherapy4▲ 17×6 topics
  8. Genomic Instability4▲ 54×2 topics
  9. Survival Analysis4▲ 22×4 topics
  10. Clinical Practice Guidelines4▲ 11×5 topics
  11. Inflammation4▲ 2.8×28 topics
  12. Neoadjuvant Therapy4▲ 24×4 topics
  13. Molecular Subtypes4▲ 65×3 topics
  14. Prognostic Markers3▲ 50×3 topics
  15. Synthetic Lethality3▲ 156×2 topics
  16. Breast Tumours3▲ 106×1 topic
  17. Chemotherapy3▲ 7.2×13 topics
  18. Treatment Response3▲ 106×1 topic
  19. BRCA Mutation3▲ 215×1 topic
  20. PARP Inhibitors3▲ 215×1 topic
  21. Tumor Microenvironment3▲ 10×7 topics
  22. Targeted Therapy3▲ 19×4 topics
  23. Epithelial-Mesenchymal Transition3▲ 43×2 topics
  24. Cancer Genomics2▲ 53×1 topic
  25. Cancer Stem Cells2▲ 89×1 topic
  26. Immunotherapy2▲ 5.5×10 topics
  27. Mutational Signatures2▲ 53×1 topic
  28. Tumor Metastasis2▲ 70×1 topic
  29. Metastatic Breast Cancer2▲ 64×2 topics
  30. Apoptosis2▲ 12×11 topics
  31. Immunity2▲ 8.9×7 topics
  32. CDK4/6 Inhibitors2▲ 128×1 topic
  33. Palbociclib2▲ 128×1 topic
  34. Innate Immunity2▲ 9.7×6 topics
  35. Transcriptional Regulation2▲ 19×6 topics
  36. Cancer Immunotherapy2▲ 19×3 topics
  37. Precision Medicine2▲ 6.2×4 topics
  38. EGFR2▲ 98×1 topic
  39. HER22▲ 98×1 topic
  40. Trastuzumab2▲ 63×2 topics

Which research topics does Breast Cancer Now publish most on?

By volume in 2022–2025: Breast Cancer Treatment Studies, PARP inhibition in cancer therapy, Cancer Cells and Metastasis and Cancer Genomics and Diagnostics.

Breast Cancer Treatment …3Breast Cancer Treatment Studies: 3 fractional worksPARP inhibition in cance…3PARP inhibition in cancer therapy: 3 fractional worksCancer Cells and Metasta…2Cancer Cells and Metastasis: 2 fractional worksCancer Genomics and Diag…2Cancer Genomics and Diagnostics: 2 fractional worksAdvanced Breast Cancer Therapies: 2 fractional worksHER2/EGFR in Cancer Research: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksDNA Repair Mechanisms1DNA Repair Mechanisms: 1 fractional worksBRCA gene mutations in cancer: 1 fractional worksEstrogen and related hormone effects: 1 fractional works
Cancer ResearchOncologyPulmonary and Respiratory MedicineMolecular Biology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Breast Cancer Treatment Studies Cancer Research 3 works
  2. 2 PARP inhibition in cancer therapy Oncology 3 works
  3. 3 Cancer Cells and Metastasis Oncology 2 works
  4. 4 Cancer Genomics and Diagnostics Cancer Research 2 works
  5. 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  6. 6 HER2/EGFR in Cancer Research Oncology 2 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 2 works
  8. 8 DNA Repair Mechanisms Molecular Biology 1 works
  9. 9 BRCA gene mutations in cancer Genetics 1 works
  10. 10 Estrogen and related hormone effects Genetics 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.9%not open42.1%

World: 28% of research is openly available.

with international co-authors43.4%domestic only56.6%

World: 19% is written across borders.

How has Breast Cancer Now's research output changed?

Output in 2018–2022 was 4% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in London

All research institutions in London

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.